Anderson C P, Tsai J M, Meek W E, Liu R M, Tang Y, Forman H J, Reynolds C P
Division of Hematology-Oncology, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, California, 90027, USA.
Exp Cell Res. 1999 Jan 10;246(1):183-92. doi: 10.1006/excr.1998.4303.
Buthionine sulfoximine (BSO) selectively inhibits glutathione (GSH) synthesis and has been used to sensitize tumor cells to alkylating agents, but has minimal single-agent cytotoxicity for most cell types. We determined the cytotoxicity of BSO for 18 (12 MYCN amplified; 6 MYCN nonamplified) human neuroblastoma cell lines using DIMSCAN, a digital image microscopy cytotoxicity assay. D-L(R:S) BSO was highly cytotoxic (>3 logs of cell kill) for most neuroblastoma cell lines, with 17/18 cell lines having IC90 values (range 2. 1->1000 microM) below equivalent steady state plasma levels of L(R:S) BSO reported in adult human trials. Cell lines with genomic amplification of MYCN were more sensitive to BSO than MYCN nonamplified cell lines (P = 0.04). D-L(R:S) BSO (500 microM for 72 h) induced apoptosis as detected by DNA laddering, nuclear morphology, and TUNEL staining of DNA fragments using flow cytometry. Maximal cell killing occurred within 48 h and was antagonized byic value in neuroblastoma.
丁硫氨酸亚砜亚胺(BSO)可选择性抑制谷胱甘肽(GSH)的合成,并已被用于使肿瘤细胞对烷化剂敏感,但对大多数细胞类型的单药细胞毒性极小。我们使用数字图像显微镜细胞毒性测定法DIMSCAN,测定了BSO对18种(12种MYCN扩增;6种MYCN未扩增)人神经母细胞瘤细胞系的细胞毒性。D-L(R:S)BSO对大多数神经母细胞瘤细胞系具有高度细胞毒性(细胞杀伤>3个对数),18种细胞系中有17种的IC90值(范围为2.1->1000微摩尔)低于成人人体试验中报道的L(R:S)BSO的等效稳态血浆水平。MYCN基因扩增的细胞系比MYCN未扩增的细胞系对BSO更敏感(P = 0.04)。D-L(R:S)BSO(500微摩尔,作用72小时)通过DNA梯状条带、核形态学以及使用流式细胞术对DNA片段进行TUNEL染色检测,诱导了细胞凋亡。最大细胞杀伤在48小时内发生,并被神经母细胞瘤中的ic值所拮抗。